PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25070259-1	2014	BACKGROUND: Nine-beta-D-arabinofuranosylguanine (ara-G), an active metabolite of nelarabine, enters leukemic cells through human Equilibrative Nucleoside Transporter 1, and is then phosphorylated to an intracellular active metabolite ara-G triphosphate (ara-GTP) by both cytosolic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.	nelarabine	81-91	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	129-167	
31335977-0	2019	High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.	nelarabine	100-110	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	5-9	
30022699-7	2019	Interestingly, of the six compounds that potently interacted with both ENT1 and ENT2 only nelarabine displayed selectivity.	nelarabine	90-100	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	71-75